Zhitong Finance App News, Watson Biotech (300142.SZ) issued an announcement. The bivalent human papillomavirus vaccine (Pichi yeast) (trade name “WALRINVAX”, hereinafter referred to as “bivalent HPV vaccine”) produced by the company's subsidiary Yuxi Zerun Biotechnology Co., Ltd. (hereinafter referred to as “Yuxi Zerun”) recently received a “Drug Registration Certificate” issued by the Tanzania Medicines and Medical Devices Authority (Tanzania MedicinesandMedical Devices Authority), double price The HPV vaccine has obtained marketing approval for the vials of the HPV vaccine in Tanzania.
Zhitongcaijing · 3d ago
Share
Listen to the news
Zhitong Finance App News, Watson Biotech (300142.SZ) issued an announcement. The bivalent human papillomavirus vaccine (Pichi yeast) (trade name “WALRINVAX”, hereinafter referred to as “bivalent HPV vaccine”) produced by the company's subsidiary Yuxi Zerun Biotechnology Co., Ltd. (hereinafter referred to as “Yuxi Zerun”) recently received a “Drug Registration Certificate” issued by the Tanzania Medicines and Medical Devices Authority (Tanzania MedicinesandMedical Devices Authority), double price The HPV vaccine has obtained marketing approval for the vials of the HPV vaccine in Tanzania.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending